Model
Edge
Alnylam Pharmaceuticals, Inc.
0001511797
Filing type
4
Filing date
Oct 2, 2025
Updated
Oct 3, 2025 ยท 3:15 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership